Ventilatory support and corticosteroid therapy in SARS-CoV-2

• Autores: F. Martínez Sagasti, Alba Palazón, Sandra Catalina García Perrote, Patricia Alonso Martínez
• Localización: Revista Española de Quimioterapia, ISSN-e 0214-3429, Vol. 34, Nº Extra 1, 2021, págs. 52-56
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • It has been almost two years since COVID-19, a disease caused by a new coronavirus called SARS-CoV-2, was declared a pandemic by the World Health Organization. The entire scientific and medical community was put to the test during the following months to find the best therapeutic strategy to save lives. Although some antivirals and anti-inflammatory drugs are being tested in different clinical trials with some controversial results, this short review will focus on corticosteroids usefulness and ventilatory support principles, as they have become two essential therapeutic pillars for those patients who need hospital admission due to respiratory failure.